Zenas BioPharma Q3 EPS $(1.65) Misses $(1.33) Estimate, Sales $10.000M

Benzinga · 1d ago
Zenas BioPharma (NASDAQ:ZBIO) reported quarterly losses of $(1.65) per share which missed the analyst consensus estimate of $(1.33) by 24.06 percent. This is a 35.25 percent decrease over losses of $(1.22) per share from the same period last year. The company reported $10.000 million in sales this quarter.